Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Cancers
|
October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases
Baylee A Porter, Candace Frerich, Muriel Lainé, et al.
The Breast Journal
|
April 28, 2007
Factors determining adequacy of axillary node dissection in breast cancer patients
Anees B Chagpar, Charles R Scoggins, Robert C G Martin, et al.
Journal of Clinical Pathology
|
October 6, 2025
Intraoperative evaluation of sentinel lymph nodes in patients with breast cancer treated with systemic neoadjuvant therapy: a systematic review and meta-analysis of diagnostic studies
Mariela Huerta-Rosario, Carlos Quispe-Vicuña, Dante Julca-Marín, et al.
American Journal of Surgery
|
September 17, 2005
Biopsy type does not influence sentinel lymph node status
Anees B Chagpar, Charles R Scoggins, Sunati Sahoo, et al.
Cancers
|
April 17, 2019
Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance
Eylem Kulkoyluoglu-Cotul, Brandi Patrice Smith, Kinga Wrobel, et al.
Archives of Pathology & Laboratory Medicine
|
August 17, 2022
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy
Sunati Sahoo, Gregor Krings, Yunn-Yi Chen, et al.
Cell Metabolism
|
January 5, 2022
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
Pravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya Nair, et al.
JAMA Network Open
|
November 14, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Asal Rahimi, Marilyn Leitch, Basak Dogan, et al.
JAMA Surgery
|
September 7, 2022
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
Marie Osdoit, Christina Yau, W Fraser Symmans, et al.
JAMA Oncology
|
September 16, 2021
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
W Fraser Symmans, Christina Yau, Yunn-Yi Chen, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Cancers
|
October 14, 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases
Baylee A Porter, Candace Frerich, Muriel Lainé, et al.
The Breast Journal
|
April 28, 2007
Factors determining adequacy of axillary node dissection in breast cancer patients
Anees B Chagpar, Charles R Scoggins, Robert C G Martin, et al.
Journal of Clinical Pathology
|
October 6, 2025
Intraoperative evaluation of sentinel lymph nodes in patients with breast cancer treated with systemic neoadjuvant therapy: a systematic review and meta-analysis of diagnostic studies
Mariela Huerta-Rosario, Carlos Quispe-Vicuña, Dante Julca-Marín, et al.
American Journal of Surgery
|
September 17, 2005
Biopsy type does not influence sentinel lymph node status
Anees B Chagpar, Charles R Scoggins, Sunati Sahoo, et al.
Cancers
|
April 17, 2019
Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance
Eylem Kulkoyluoglu-Cotul, Brandi Patrice Smith, Kinga Wrobel, et al.
Archives of Pathology & Laboratory Medicine
|
August 17, 2022
Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy
Sunati Sahoo, Gregor Krings, Yunn-Yi Chen, et al.
Cell Metabolism
|
January 5, 2022
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
Pravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya Nair, et al.
JAMA Network Open
|
November 14, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial
Asal Rahimi, Marilyn Leitch, Basak Dogan, et al.
JAMA Surgery
|
September 7, 2022
Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
Marie Osdoit, Christina Yau, W Fraser Symmans, et al.
JAMA Oncology
|
September 16, 2021
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
W Fraser Symmans, Christina Yau, Yunn-Yi Chen, et al.
Page
of 7